О. Д. Остроумова

2.5k total citations
295 papers, 707 citations indexed

About

О. Д. Остроумова is a scholar working on Cardiology and Cardiovascular Medicine, Neurology and Epidemiology. According to data from OpenAlex, О. Д. Остроумова has authored 295 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Cardiology and Cardiovascular Medicine, 66 papers in Neurology and 62 papers in Epidemiology. Recurrent topics in О. Д. Остроумова's work include Blood Pressure and Hypertension Studies (72 papers), Neurological Disorders and Treatments (63 papers) and Healthcare Systems and Public Health (39 papers). О. Д. Остроумова is often cited by papers focused on Blood Pressure and Hypertension Studies (72 papers), Neurological Disorders and Treatments (63 papers) and Healthcare Systems and Public Health (39 papers). О. Д. Остроумова collaborates with scholars based in Russia, United States and Croatia. О. Д. Остроумова's co-authors include А. И. Кочетков, В. А. Парфенов, А. П. Переверзев, О. Н. Ткачева, Д. А. Сычев, Yu. V. Kotovskaya, Yury P. Zinchenko, В. В. Захаров, Fedin Ai and Е. В. Ших and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hypertension and European Psychiatry.

In The Last Decade

О. Д. Остроумова

209 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
О. Д. Остроумова Russia 10 264 177 127 84 71 295 707
Janine Gronewold Germany 15 230 0.9× 98 0.6× 109 0.9× 120 1.4× 100 1.4× 45 722
Luis Castilla‐Guerra Spain 15 154 0.6× 117 0.7× 214 1.7× 99 1.2× 51 0.7× 65 743
Aozhou Wu United States 14 227 0.9× 130 0.7× 92 0.7× 114 1.4× 200 2.8× 45 1.0k
Emer R. McGrath United States 17 332 1.3× 86 0.5× 221 1.7× 101 1.2× 172 2.4× 40 916
Lana Fani Netherlands 15 69 0.3× 85 0.5× 129 1.0× 52 0.6× 175 2.5× 22 693
Kendra Davis‐Plourde United States 12 192 0.7× 82 0.5× 202 1.6× 63 0.8× 213 3.0× 29 804
M. Garcia United States 13 147 0.6× 59 0.3× 87 0.7× 76 0.9× 276 3.9× 17 1.0k
Zhi Geng China 16 95 0.4× 99 0.6× 120 0.9× 47 0.6× 41 0.6× 55 644
Chun-Chuan Shih Taiwan 18 95 0.4× 67 0.4× 195 1.5× 67 0.8× 46 0.6× 45 880
S. Sans Spain 8 144 0.5× 68 0.4× 66 0.5× 54 0.6× 140 2.0× 15 545

Countries citing papers authored by О. Д. Остроумова

Since Specialization
Citations

This map shows the geographic impact of О. Д. Остроумова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. Д. Остроумова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. Д. Остроумова more than expected).

Fields of papers citing papers by О. Д. Остроумова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by О. Д. Остроумова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. Д. Остроумова. The network helps show where О. Д. Остроумова may publish in the future.

Co-authorship network of co-authors of О. Д. Остроумова

This figure shows the co-authorship network connecting the top 25 collaborators of О. Д. Остроумова. A scholar is included among the top collaborators of О. Д. Остроумова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with О. Д. Остроумова. О. Д. Остроумова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Конради, А. О., Е. И. Баранова, А. S. Galyavich, et al.. (2024). Current approaches to the treatment of hypertensive patients in view of modern guidelines. CARDIOVASCULAR THERAPY AND PREVENTION. 23(8). 4140–4140. 2 indexed citations
2.
Полуэктов, М Г, et al.. (2024). Management of patients with insomnia and polymorbidity. A draft of the clinical guidelines. S S Korsakov Journal of Neurology and Psychiatry. 124(5). 39–39.
3.
Конради, А. О., Е. И. Баранова, А. S. Galyavich, et al.. (2023). Hypertension in periand postmenopausal women: mechanisms, management, observation. SHILAP Revista de lepidopterología. 29(1). 5729–5729. 2 indexed citations
4.
Остроумова, О. Д., et al.. (2023). Metabolically associated fatty liver disease: the role of ademetionine. Фарматека. 1-2_2023. 54–62.
5.
Полуэктов, М Г, et al.. (2023). Management of patients with insomnia and polymorbidity: expert consensus. S S Korsakov Journal of Neurology and Psychiatry. 123(5). 49–49. 4 indexed citations
6.
Остроумова, О. Д., et al.. (2022). Drug-induced tremor. SHILAP Revista de lepidopterología. 14(2). 4–10.
7.
Остроумова, О. Д., et al.. (2021). Stroke and COVID‑19. Medical alphabet. 26–30. 1 indexed citations
8.
Bure, Irina V., К. Б. Мирзаев, О. Д. Остроумова, et al.. (2021). MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug Metabolism and Personalized Therapy. 37(1). 41–46. 3 indexed citations
9.
Ткачева, О. Н., et al.. (2020). Prevalence of geriatric syndromes in persons over 65 years: the first results of the EVCALIPT study. SHILAP Revista de lepidopterología. 25(10). 3985–3985. 11 indexed citations
10.
Остроумова, О. Д., et al.. (2020). Arterial hypertension and cognitive impairment: multimodal approach for patient care and nicergoline use. SHILAP Revista de lepidopterología. 72–80. 1 indexed citations
11.
Кочетков, А. И., et al.. (2020). Pathogenetic mechanisms of drug-induced liver damage. Siberian medical review. 36–50.
12.
Остроумова, О. Д., et al.. (2020). Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes. SHILAP Revista de lepidopterología. 23(1). 72–87. 3 indexed citations
13.
Остроумова, О. Д., et al.. (2019). Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors. CARDIOVASCULAR THERAPY AND PREVENTION. 18(5). 128–137.
14.
Парфенов, В. А., et al.. (2019). <p>Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments</p>. Neuropsychiatric Disease and Treatment. Volume 15. 1381–1402. 38 indexed citations
15.
Кочетков, А. И., et al.. (2019). The application of the STOPP/START criteria in the elderly patients with type 2 diabetes mellitus and essential hypertension at the endocrinology department of a multidisciplinary hospital. Arterial’naya Gipertenziya (Arterial Hypertension). 25(3). 214–224. 2 indexed citations
16.
Переверзев, А. П., О. Д. Остроумова, О. Н. Ткачева, & Yu. V. Kotovskaya. (2019). Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia. SHILAP Revista de lepidopterología. 7(4). 190–199. 3 indexed citations
17.
Остроумова, О. Д., et al.. (2018). Arterial hypertension, cognitive disorders and dementia: a view of a cardiologist. S S Korsakov Journal of Neurology and Psychiatry. 118(9). 117–117. 4 indexed citations
18.
Остроумова, О. Д., et al.. (2017). Blood Pressure Variability. Visit-to-Visit Blood Pressure Variability. Kardiologiia. 17(11). 68–75. 7 indexed citations
19.
Остроумова, О. Д., et al.. (2001). THE USAGE OF PHYSIOTENSE IN ELDERLY PATIENTS WITH ESSENTIAL HYPERTENSION. SHILAP Revista de lepidopterología.
20.
Остроумова, О. Д., et al.. (2000). SPECTRAL ANALYSIS OF HEART RATE FLUCTUATIONS IN PATIENTS WITH ESSENTIAL HYPERTENSION. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026